ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SCMP Sucampo Pharmaceuticals, Inc. (delisted)

18.00
0.00 (0.00%)
Pre Market
Last Updated: 19:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 18.00
Ask Price 18.00
News -
Share Name Share Symbol Market Stock Type
Sucampo Pharmaceuticals, Inc. (delisted) SCMP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 18.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
18.00
Trades Shares Traded Average Volume
0 0 -
Last Trade Type Quantity Price Currency
- 0 US$ 18.00 USD

Sucampo Pharmaceuticals, Inc. (delisted) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 844.53M - - - -3.92
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sucampo Pharmaceuticals, Inc. (delisted) News

Real-Time news about Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SCMP Message Board. Create One! See More Posts on SCMP Message Board See More Message Board Posts

Historical SCMP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Sucampo Pharmaceuticals, Inc. (delisted) Description

Sucampo Pharmaceuticals Inc is a part of the healthcare sector in the United States. As a global pharmaceutical company, it commercializes drugs for the treatment of various gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It currently generates revenue mainly from product royalties, product sales, upfront and milestone payments, and reimbursements for development activities.

Your Recent History

Delayed Upgrade Clock